Takeda Pharmaceutical
(NYSE) TAK
Takeda Pharmaceutical Financials at a Glance
Market Cap
$57.06B
Revenue (TTM)
$4.49T
Net Income (TTM)
$114.75B
EPS (TTM)
$0.24
P/E Ratio
72.88
Dividend
$0.66
Beta (Volatility)
0.33 (Low)
Dividend
$0.66
Beta (Volatility)
0.33 (Low)
Price
$17.91
Volume
69,567
Open
$18.12
Price
$17.91
Volume
69,567
Open
$18.12
Previous Close
$17.91
Daily Range
$17.88 - $18.19
52-Week Range
$12.99 - $18.82
Dividend
$0.66
Beta (Volatility)
0.33 (Low)
Price
$17.91
Volume
69,567
Open
$18.12
Previous Close
$17.91
Daily Range
$17.88 - $18.19
52-Week Range
$12.99 - $18.82
TAK News
TAK: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Takeda Pharmaceutical
Industry
Pharmaceuticals
Sector
Health CareEmployees
47,455
CEO
Christophe Weber, PhD
Website
www.takeda.comHeadquarters
Tokyo, 103-8668, JP
TAK Financials
Key Financial Metrics (TTM)
Gross Margin
59%
Operating Margin
10%
Net Income Margin
3%
Return on Equity
2%
Return on Capital
4%
Return on Assets
1%
Earnings Yield
1.37%
Dividend Yield
0.04%
Payout Ratio
2.77%
Stock Overview
Market Cap
$57.06B
Shares Outstanding
3.16B
Volume
69.57K
Short Interest
0.00%
Avg. Volume
2.90M
Financials (TTM)
Gross Profit
$3.00T
Operating Income
$342.59B
EBITDA
$1.21T
Operating Cash Flow
$1.06T
Capital Expenditure
$200.79B
Free Cash Flow
$856.39B
Cash & ST Invst.
$405.59B
Total Debt
$4.52T
Takeda Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.21T
+6.0%
Gross Profit
$660.35B
-9.2%
Gross Margin
54.43%
N/A
Market Cap
$57.06B
N/A
Market Cap/Employee
$1.16M
N/A
Employees
49,281
N/A
Net Income
$105.51B
+343.5%
EBITDA
$456.22B
+136.4%
Quarterly Fundamentals
Net Cash
$4.09T
+5.1%
Accounts Receivable
$758.44B
+3.2%
Inventory
$1.41T
+13.0%
Long Term Debt
$4.27T
-9.2%
Short Term Debt
$583.55B
+330.8%
Return on Assets
0.73%
N/A
Return on Invested Capital
3.59%
N/A
Free Cash Flow
$317.47B
-6.3%
Operating Cash Flow
$360.04B
-6.2%